Doctors Drugs Pharmaceuticals Pharmacy 
Policy Prescription
FEBRUARY 9, 2022
Mark Cuban’s new online pharmacy venture – the Mark Cuban Cost Plus Drug Company (“Cost Plus Drug”) – will not help overcome the biggest obstacle to drug affordability in America, which is drug company monopolies on patented brand name prescription drugs. Cuban refers to “basic prescription medications.”
Drug Discovery World
JANUARY 17, 2023
Oregon State University College of Pharmacy scientists have shown that lipid nanoparticles and messenger RNA could treat blindness associated with a rare genetic condition. . The post Lipid nanoparticles and mRNA used to treat hereditary blindness appeared first on Drug Discovery World (DDW).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Perficient: Drug Development
FEBRUARY 20, 2024
Prescription drugs reach patients through a complex web of entities. Among these, pharmacy benefit managers (PBMs) play a crucial role, handling reimbursements and negotiations with drug manufacturers and pharmacies. This ongoing struggle contributes to the broader atmosphere of tension within the pharmaceutical sector.
The Pharma Data
SEPTEMBER 21, 2020
Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat those who take them. . Acella has received four reports of adverse events that were related to these drugs, which are sold in 100 tablet bottles with expiration dates of October and November 2020.
The Pharma Data
DECEMBER 17, 2020
With years of pharmaceutical expertise to her credit, Dr. Johnson first garnered inspiration for her professional future during her formative years. Doctor Johnson has had an inspiring career that encompasses several aspects of the pharmacy industry. Dr. Johnson assists in interpreting the results when they become available.
The Pharma Data
OCTOBER 29, 2020
29, 2020 – More than one-third of older Americans are prescribed drugs they may not need, a new study finds. In fact, these patients are prescribed twice as many drugs as needed and are nearly twice as likely to be hospitalized or wind up in the emergency department. THURSDAY, Oct. “As the age of the U.S.
Drug Target Review
DECEMBER 22, 2023
The regulatory science project I pursued for my first master’s degree titled, “21st Century Pharmaceutical Excipients: Consequences of a Global Supply Chain and Lack of Excipient Regulations” aimed to draw attention to the risks created by the lack of sufficient oversight of the pharmaceutical excipient supply chain.
Expert insights. Personalized for you.
52 
Let's personalize your content